| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 310.059 | 342.757 | 391.423 | 385.881 | 363.063 | 306.014 | 344.249 | 323.092 | 406.916 | 475.643 |
| Total Income - EUR | 314.957 | 344.108 | 394.506 | 385.899 | 363.068 | 345.795 | 344.347 | 323.229 | 406.928 | 475.651 |
| Total Expenses - EUR | 304.768 | 310.701 | 367.778 | 420.891 | 370.097 | 341.482 | 342.696 | 339.946 | 389.227 | 486.859 |
| Gross Profit/Loss - EUR | 10.189 | 33.407 | 26.728 | -34.992 | -7.029 | 4.313 | 1.651 | -16.718 | 17.701 | -11.208 |
| Net Profit/Loss - EUR | 10.189 | 29.985 | 18.219 | -35.754 | -7.029 | 4.313 | 1.651 | -16.718 | 17.701 | -11.208 |
| Employees | 30 | 27 | 32 | 33 | 33 | 26 | 25 | 23 | 23 | 24 |
Check the financial reports for the company - Dacmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 426.099 | 393.509 | 510.662 | 469.124 | 434.323 | 414.127 | 373.881 | 481.262 | 451.571 | 450.609 |
| Current Assets | 21.795 | 32.602 | 31.992 | 21.929 | 31.646 | 39.435 | 56.312 | 38.077 | 91.560 | 83.475 |
| Inventories | 0 | 17 | 696 | 0 | 0 | 0 | 0 | 0 | 0 | 84 |
| Receivables | 3.993 | 22.799 | 17.166 | 9.254 | 9.426 | 12.785 | 16.315 | 8.107 | 46.442 | 5.967 |
| Cash | 17.802 | 9.786 | 14.130 | 12.675 | 22.220 | 26.649 | 39.998 | 29.970 | 45.118 | 77.424 |
| Shareholders Funds | 242.369 | 269.882 | 431.556 | 387.882 | 373.341 | 370.576 | 364.009 | 456.893 | 473.208 | 459.356 |
| Social Capital | 122.880 | 121.626 | 119.568 | 117.374 | 115.101 | 112.919 | 110.415 | 110.757 | 110.422 | 109.804 |
| Debts | 205.526 | 156.229 | 111.098 | 103.171 | 92.627 | 82.986 | 66.184 | 68.580 | 69.923 | 74.729 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dacmed Srl